AMPEL BioSolutions' ORKIDS Trial Shows Krill Oil Supplementation Improves Lupus Symptoms
AMPEL BioSolutions, in collaboration with Lupus Therapeutics and Aker BioMarine, recently published exciting results from their ORKIDS clinical trial. This study revealed that Omega-3-rich Krill Oil supplementation can improve disease activity in patients with autoimmune Lupus. The ORKIDS trial was a multicenter, randomized, double-blind, placebo-controlled study designed to test the effects of Superba Boost Krill Oil (AKBM-3031) on Lupus disease activity. The results showed that supplementing with Krill Oil led to a significant improvement in the Omega-3 index of Lupus patients. Notably, this improvement in Omega-3 levels was maintained for up to 48 weeks during the open-label extension phase of the trial.
AMPEL BioSolutions' ORKIDS Trial Shows Krill Oil Supplementation Improves Lupus Symptoms